NCT03359980View on ClinicalTrials.gov

Treatment of Steroid Refractory Gastro-intestinal Acute GVHD afteR AllogeneiC HSCT With fEcal Microbiota tranSfer

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 13, 2018

Primary Completion Date

February 25, 2020

Study Completion Date

November 26, 2020

Conditions
Fecal Microbiota Transplantation
Interventions
DRUG

fecal microbiota transfer

transfer of fecal microbiota from healthy donors to the patients

Trial Locations (16)

168

Gemelli Hospital, Roma

25030

CHRU Besançon, Besançon

31100

IUCT Oncopole, Toulouse

42270

Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez

44000

CHU Nantes, Nantes

49933

CHU Angers, Angers

59037

CHRU Lille, Lille

67098

CHU Strasbourg, Strasbourg

69310

Centre Hospitalier Lyon Sud, Pierre-Bénite

75012

Hôpital Saint Antoine, Paris

80054

CHU Amiens, Amiens

87000

CHU Limoges, Limoges

94000

Hôpital Henri Mondor, Créteil

80-952

Klinika Hematologii i Transplantologii, Gdansk

40-032

Public Clinic Hospital, Katowice

50-556

University Clinical hospital, Wroclaw

Sponsors

Lead Sponsor

MaaT Pharma
All Listed Sponsors
lead

MaaT Pharma

INDUSTRY